4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-22-058619
President and Chief Executive sold 1,526 shares at $9.60 ($14,650)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Curran Terrie President and Chief Executive | 2022-11-21 | Sale | −1,526 | $9.60 | $14,650 | 83,720 | D |
| Open-market sales · 1,526 sh · avg $9.60 · $14,650 | |||||||
Loading xslF345X03/doc4.xml…